MAI Capital Management’s Niagen Bioscience NAGE Stock Holding History

MAI Capital Management’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.9K	Sell	12,202 -1,671	-12%	-$6.78K	﹤0.01%	2002
2026 Q1	$61.2K	Buy	13,873 +3,155	+29%	+$17K	﹤0.01%	2112
2025 Q4	$68.2K	Buy	10,718 +51	+0.5%	+$355	﹤0.01%	1840
2025 Q3	$99.5K	Hold	10,667	–	–	﹤0.01%	1577
2025 Q2	$154K	Hold	10,667	–	–	﹤0.01%	1297
2025 Q1	$73.6K	Hold	10,667	–	–	﹤0.01%	1545
2024 Q4	$56.6K	Hold	10,667	–	–	﹤0.01%	1706
2024 Q3	$38.9K	Sell	10,667 -1,384	-11%	-$4.36K	﹤0.01%	1061
2024 Q2	$32.9K	Buy	12,051 +1,384	+13%	+$4.63K	﹤0.01%	1212
2024 Q1	$37.1K	Hold	10,667	–	–	﹤0.01%	1193
2023 Q4	$15.3K	Hold	10,667	–	–	﹤0.01%	1088
2023 Q3	$15.6K	Hold	10,667	–	–	﹤0.01%	1034
2023 Q2	$16.7K	Hold	10,667	–	–	﹤0.01%	1030
2023 Q1	$16.3K	Hold	10,667	–	–	﹤0.01%	1014
2022 Q4	$17.9K	Hold	10,667	–	–	﹤0.01%	983
2022 Q3	$13K	Hold	10,667	–	–	﹤0.01%	921
2022 Q2	$18K	Hold	10,667	–	–	﹤0.01%	868
2022 Q1	$26K	Hold	10,667	–	–	﹤0.01%	895
2021 Q4	$40K	Hold	10,667	–	–	﹤0.01%	884
2021 Q3	$67K	Hold	10,667	–	–	﹤0.01%	763
2021 Q2	$105K	Hold	10,667	–	–	﹤0.01%	726
2021 Q1	$100K	Hold	10,667	–	–	﹤0.01%	692
2020 Q4	$51K	Hold	10,667	–	–	﹤0.01%	663
2020 Q3	$43K	Hold	10,667	–	–	﹤0.01%	574
2020 Q2	$49K	Hold	10,667	–	–	﹤0.01%	534
2020 Q1	$35K	Hold	10,667	–	–	﹤0.01%	531
2019 Q4	$46K	Hold	10,667	–	–	﹤0.01%	575
2019 Q3	$42K	Hold	10,667	–	–	﹤0.01%	517
2019 Q2	$50K	Hold	10,667	–	–	﹤0.01%	533
2019 Q1	$45K	Hold	10,667	–	–	﹤0.01%	464
2018 Q4	$37K	Hold	10,667	–	–	﹤0.01%	438
2018 Q3	$46K	Hold	10,667	–	–	﹤0.01%	475
2018 Q2	$40K	Hold	10,667	–	–	﹤0.01%	478
2018 Q1	$45K	Hold	10,667	–	–	﹤0.01%	460
2017 Q4	$63K	Hold	10,667	–	–	﹤0.01%	467
2017 Q3	$46K	Hold	10,667	–	–	﹤0.01%	441
2017 Q2	$41K	Hold	10,667	–	–	﹤0.01%	450
2017 Q1	$29K	Hold	10,667	–	–	﹤0.01%	450
2016 Q4	$35K	Hold	10,667	–	–	﹤0.01%	436
2016 Q3	$32K	Hold	10,667	–	–	﹤0.01%	442
2016 Q2	$44K	Buy	+10,667	New	+$50.5K	﹤0.01%	416

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

MAI Capital Management's NAGE Position: Q2 2026 in Review

MAI Capital Management reduced its Niagen Bioscience (NAGE) stake by 12% in Q2 2026, selling an estimated $6.78K and leaving 12,202 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2002.

MAI Capital Management first reported a position in NAGE in Q2 2016 and has held it in 41 quarters since. The position peaked at $154K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

MAI Capital Management held 12,202 shares of Niagen Bioscience worth $38.9K as of Q2 2026.
MAI Capital Management sold 1,671 Niagen Bioscience shares in Q2 2026, an estimated $6.78K.
Niagen Bioscience made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #2002 holding.
MAI Capital Management first reported a position in Niagen Bioscience in Q2 2016 and has held it in 41 quarters since.
MAI Capital Management's Niagen Bioscience position peaked at $154K in Q2 2025.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.